Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany ; volume:25 ; number:1 ; day:16 ; month:5 ; year:2024 ; pages:1-9 ; date:12.2024
The journal of headache and pain ; 25, Heft 1 (16.5.2024), 1-9, 12.2024
- Urheber
-
Scheffler, Armin
Wenzel, Pauline
Bendig, Merle
Eikermann, Astrid
Basten, Jale
Kleinschnitz, Christoph
Nsaka, Michael
Lindner, Diana
Naegel, Steffen
Burow, Philipp
Fleischmann, Robert
Holle, Dagny
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-024-01788-1
- URN
-
urn:nbn:de:101:1-2407252124228.615241752958
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scheffler, Armin
- Wenzel, Pauline
- Bendig, Merle
- Eikermann, Astrid
- Basten, Jale
- Kleinschnitz, Christoph
- Nsaka, Michael
- Lindner, Diana
- Naegel, Steffen
- Burow, Philipp
- Fleischmann, Robert
- Holle, Dagny
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treating insomnia with medications
Tolerability of Antihypertensive Medications: The Influence of Age
Serum CGRP in migraine patients using erenumab as preventive treatment
Preventive strategies of adverse events with potentially dangerous medications
Preventive strategies of adverse events with potentially dangerous medications
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Efficacy, tolerability, and retention of antiseizure medications in PRRT2-associated infantile epilepsy
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments
Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis
Treating insomnia with medications
Tolerability of Antihypertensive Medications: The Influence of Age
Serum CGRP in migraine patients using erenumab as preventive treatment
Preventive strategies of adverse events with potentially dangerous medications
Preventive strategies of adverse events with potentially dangerous medications
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Efficacy, tolerability, and retention of antiseizure medications in PRRT2-associated infantile epilepsy
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments
Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis
Treating insomnia with medications
Tolerability of Antihypertensive Medications: The Influence of Age
Serum CGRP in migraine patients using erenumab as preventive treatment
Preventive strategies of adverse events with potentially dangerous medications
Preventive strategies of adverse events with potentially dangerous medications
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Efficacy, tolerability, and retention of antiseizure medications in PRRT2-associated infantile epilepsy
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
Three-month treatment outcome of medication-overuse headache according to classes of overused medications, use of acute medications, and preventive treatments